Titan Medical Inc. (the "Company") (TSX VENTURE: TMD)(OTCQX: TITXF)

announced today that Dr. Dennis L. Fowler, MD, MPH has joined the

Company as a consultant for the development of the Company's

Insertable Robotic Effector Platform ("IREP") for single-site surgery.

"As a co-inventor of the IREP, Dr. Fowler's in-depth expertise in

developing robotic surgical technologies and in performing

laparoscopic surgery will be of great value to our team," said Craig

Leon, Chief Executive Officer of Titan Medical Inc. "We believe, the

advisory role he is going to take in the development of our

single-site robotic surgery technology will be essential as we advance

the IREP program from the development stage to clinical trials."

Dr. Fowler is Medical Director of the New York Presbyterian

Hospital/Columbia Simulation Center and Director of the Reemtsma

Center for Innovation and Outcomes Research in the Department of

Surgery at Columbia. He joined the minimal access surgery field in

1990 when laparoscopic technology became available, and developed

several new techniques for laparoscopic surgery, including

laparoscopic colon surgery. In 2000, New York Presbyterian Hospital

(NYPH) recruited him from his directorship of the Allegheny Center for

Laparoscopic and Minimally Invasive Surgery in Pittsburgh to lead the

newly formed Minimal Access Surgery Center (MASC) at both the Columbia

and the Cornell campuses of NYPH. He continued in that role from

2000-2008 during which time he also served as Chief of the Division of

General Surgery at Weill Cornell Medical College (2002-2004) and Vice

President and Medical Director for Perioperative Services at

NYPH/Columbia (2004-2008).

While Director of MASC, Dr. Fowler pioneered the field of minimal

access surgery as an innovator of both devices and procedures. His

work with MASC involved surgical skills training and assessment for

Columbia University Department of Surgery residents as well as for

licensed practitioners. He has published extensively on the topics of

minimally invasive surgery, technology development, and surgical

education. In 2008, he received his MPH degree from Columbia

University, and now focuses on improving healthcare outcomes through

health systems research; designing, testing, and commercializing

innovative healthcare technology (e.g., surgical robotics to reduce

the complexity of minimal access surgery); and designing, testing, and

implementing simulation training for healthcare providers.

At the very beginning of his career, Dr. Fowler was a Surgical

Endoscopy Fellow in 1979-80 at the Massachusetts General Hospital

after having previously graduated from medical school and having

completed a general surgery residency in Kansas City.

About Titan Medical Inc.

Titan Medical Inc. is a Canadian public company (TSX VENTURE:

TMD)(OTCQX: TITXF) focused on the design, development and

commercialization of new robotic surgical technologies. The Company is

advancing the development of a robust product portfolio with the

objective to meet current needs in surgical procedures which would

benefit all stakeholders, including patients, surgeons, and hospitals.

The Company's product portfolio includes solutions for both

single-site and multi-port surgical procedures that are under-served

by robotic and non-robotic minimally invasive techniques. Robotic

surgery has developed over the past 10 years into a proven and growing

method of treatment. According to a Robotic Surgery Equipment

Manufacturing report, industry revenue is projected to increase at an

average annual rate of 14.9% to $4.2 billion from 2011 to 2016. For

more information, visit the Company's website at

Forward Looking Statements

This news release contains "forward-looking statements" which reflect

the current expectations of management of the Company's future growth,

results of operations, performance and business prospects and

opportunities. Wherever possible, words such as "may", "would",

"could", "will", "anticipate", "believe", "plan", "expect", "intend",

"estimate", "potential for" and similar expressions have been used to

identify these forward-looking statements. These statements reflect

management's current beliefs with respect to future events and are

based on information currently available to management.

Forward-looking statements involve significant risks, uncertainties

and assumptions. Many factors could cause the Company's actual

results, performance or achievements to be materially different from

any future results, performance or achievements that may be expressed

or implied by such forward-looking statements, including, without

limitation, those listed in the "Risk Factors" section of the

Company's Annual Information Form dated March 30, 2012 (which may be

viewed at Should one or more of

these risks or uncertainties materialize, or should assumptions

underlying the forward looking statements prove incorrect, actual

results, performance or achievements may vary materially from those

expressed or implied by the forward-looking statements contained in

this news release. These factors should be considered carefully and

prospective investors should not place undue reliance on the

forward-looking statements. Although the forward-looking statements

contained in the news release are based upon what management currently

believes to be reasonable assumptions, the Company cannot assure

prospective investors that actual results, performance or achievements

will be consistent with these forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as

that term is defined in policies of the TSX Venture Exchange) accepts

responsibility for the adequacy or accuracy of this release.